LENZ Therapeutics (LENZ) Property, Plant & Equipment (Net) (2020 - 2026)

LENZ Therapeutics (LENZ) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 LENZ Therapeutics 177.61 Mn -80.77 Mn 825,000.00 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.19 Mn
Dec 31, 2025 1.19 Mn
Sep 30, 2025 1.26 Mn
Sep 30, 2025 1.26 Mn
Jun 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 926,000.00
Mar 31, 2025 926,000.00
Dec 31, 2024 651,000.00
Dec 31, 2024 651,000.00
Sep 30, 2024 372,000.00
Sep 30, 2024 372,000.00
Jun 30, 2024 164,000.00
Jun 30, 2024 164,000.00
Mar 31, 2024 49,000.00
Mar 31, 2024 49,000.00
Dec 31, 2023 54,000.00
Dec 31, 2023 54,000.00